SoVarGen
About:
SoVarGen is a biotechnology company that provides drugs for patients with neurological diseases.
Website: http://sovargen.com
Top Investors: Company K Partners, HB Investment, NH Investment & Securities, BNK Venture Capital, Medivate Partners
Description:
Total Funding Amount:
35B KRW
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2018-01-01
Contact Email:
sovargen(AT)sovargen.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2020-09-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai